Co-Investigators and Contributors to the STROKE-INF Trial

NEUROLOGY/2016/726109

Co-investigators and Contributors to the STROKE-INF Trial

Co-Investigators

Hugh Marcus MD, PhD (St George’s Medical School, Chair, Steering Committee), Helen Rodgers MD, PhD (Newcastle University, Chair, Data Management Committee), Irene Rebello-Mesa PhD (Biostatistics Department, King’s College London, Trial Statistician), Martin Gulliford MD, PhD (Division of Health and Social Care Research, King’s College London, Member, Coordinating Centre), Matthew Simpson, MSc (King’s Healthcare Partners Joint Clinical Trials Office, Lead, Data management), Mohammed Al-Bazzaz,MD (Barnsley Hospital, Site Investigator), Ali Mehrzad,MD (Bishop Auckland Hospital, Site Investigator), Anand Nair, MD (Calderdale Royal Hospital, Site Investigator), ArindamKar, MD (Charing Cross Hospital, Site Investigator), Ramachandran Sivakumar, MD (Colchester University Hospital,Site Investigator), Prabal Datta, MD (Dewsbury District Hospital, Site Investigator), Dinesh Chadha, MD (Doncaster Royal Infirmary, Site Investigator), ConradAthulathmudali, MD (Eastbourne District General Hospital, Site Investigator), Jonathan Birns, MD, PhD (Guy’s and St Thomas’ Hospital, Site Investigator), MohibburChowdhury, MD (Ipswich Hospital, Site Investigator), James Kennedy, MD, PhD (John Radcliffe Hospital, Site Investigator), Ilsa Berger MD (Kent and Canterbury Hospital, Site Investigator), Mehool Patel, MD (Lewisham Hospital, Site Investigator), A PusalkarMD, (Lister Hospital, Site Investigator), LakshmananSekaran, MD (Luton and Dunstable Hospital, Site Investigator), MustaqWani MD (Morriston Hospital, Site Investigator), Ava Jackson, MD (Newham University Hospital, Site Investigator), Indira Natarajan, MD (University Hospital of North Staffordshire, Site Investigator), Christopher Price, MD, PhD (North Tyneside General Hospital, Site Investigator), Harish Bhat, MD (Princess of Wales Hospital, Site Investigator), Laszlo Sztriha MD, PhD (Princes Royal University Hospital, Site Investigator), GunaratnamGunathilagan, MD (Queen Elizabeth The Queen Mother Hospital, Site Investigator), SreemanAndole, MD (Queens Hospital, Site Investigator),Timothy England, MD (The Royal Derby Hospital, Site Investigator), Yaqoob Bhat, MD (Royal Gwent Hospital, Site Investigator), Patrick Gompertz, MD (Royal London Hospital, Site Investigator), Kath Pasco, MD (Royal Surrey County Hospital,Site Investigator), ChakravarthiRajkumar, MD, PhD (Brighton and Sussex University Hospital, Site Investigator), Paul Guyler, MD (Southend University Hospital, Site Investigator), Barry Moynihan, MD (St George’s Hospital, Site Investigator), Martin Brown, MD, PhD (University College London Hospital, Site Investigator), Bernard Esisi, MD (University Hospital of North Durham, Site Investigator),Hamsaraj Shetty, MD (University Hospital Of Wales, Site Investigator), David Hargroves, MD (William Harvey Hospital, Site Investigator), Khalid Rashed, MD (Yeovil District Hospital, Site Investigator).

Contributors

Statistical Advice: Andrew Grieve, PhD & Salma Ayis PhD (Division of Health and Social Care Research, King’s College, London); Study Monitoring: Jackie Pullen, Helen Critchley; Michelle GilesJane Good (King’s Healthcare Partners Joint Clinical Trials Office); Network Support and Coordination: Ann-Marie Murtagh Gaye Hadfield (Stroke Research Network of the National Institute of Health Research); Data Collection:Michael Hong, RamyaDhonti, Jaya Buchupalli; Trial Administration: Amanda Davies, Iram Ahmed, Claire Potter and Isabelle Leung (Trial Coordinating Centre, King’s College London)